Dr. Jeffrey Wolf Healthcare Provider

Dr. Wolf established the country’s first community hospital-based Bone Marrow Transplant unit at Alta Bates Medical Center in Berkeley. While there, he was among the first to study Bortezomib (Velcade) and Lenalidomide (Revlimid) in patients with myeloma. 

In 2007, he joined the faculty at the University of California, San Francisco, where, along with Dr. Tom Martin, he helped to establish the largest myeloma program on the West Coast. This program currently treats over 3,500 active myeloma patients, with doctors performing over 130 myeloma stem cell transplants and 50 Myeloma CAR-T cell therapies a year. UCSF also has a robust clinical research program and a laboratory-based research program specializing in the development of new drugs and new targets for the treatment of myeloma. Over the last 20 years, he has become an internationally recognized opinion leader in the myeloma field and has continued to treat patients, participate in research studies, and speak at numerous meetings around the world.

In addition to his work life, Dr. Wolf has found time to travel extensively, especially in the Himalayas where he has volunteered his time to treat patients at a cancer clinic in Bhaktapur, Nepal. In addition to working there, he has arranged a very large donation of radiation and radiology equipment to help this cancer center.

Throughout his life he has been active in sports, although his days on basketball and tennis courts have given way to hiking all over the world and, more recently, increased time on a bicycle seat. He very much looks forward to joining the myeloma community on its bicycle adventure on the Columbia River and especially to joining the multiple myeloma-connected riders on this important effort to fund myeloma research. 

”We are close to curing myeloma but need everybody’s support to get there,” he said. 

Riding to celebrate progress • Supporting MMRF’s research • Riding alongside patients & caregivers • Showing my patients that I am part of the cure
Jeff Wolf
It is to that end that we are all riding to raise the funding (and awareness) that will enable us to reach a cure in the next few years. I…
Read More
The Multiple Myeloma Research Foundation (MMRF) is the largest nonprofit in the world solely focused on accelerating a cure for each and every multiple myeloma patient. We drive the development and delivery of next-generation therapies, leverage data to identify optimal and more personalized treatment approaches, and empower myeloma patients and the broader community with information and resources to extend their lives. Central to our mission is our commitment to advancing health equity so that all myeloma patients can benefit from the scientific and clinical advances we pursue. Since our inception, the MMRF has committed over $500 million for research, opened nearly 100 clinical trials, and helped bring 15+ FDA-approved therapies to market, which have tripled the life expectancy of myeloma patients. To learn more, visit www.themmrf.org.

Learn More

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity.

Learn more About Johnson & Johnson inovative medicine Learn more About Johnson & Johnson Follow us on @JanssenUS And @JNJInnovMed